| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04685616 | Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | Hodgkin Lymphoma | Recruiting |
| Phase 2 | |||
| NCT07320001 | Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic… | Lymphatic Abnormality | Not Yet Recruiting |
| NCT03407144 | Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With… | Hodgkin Lymphoma | Active, Not Recruiting |
| NCT03755804 | Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 | Hodgkin Lymphoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT03033914 | A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical… | Hodgkin Lymphoma | Active, Not Recruiting |
| Not specified | |||
| NCT06189092 | Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective… | Vascular Malformations | Recruiting |